These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37994559)

  • 1. Hydrazone-sulfonate hybrids as potential cholinesterase inhibitors: design, synthesis and molecular modeling simulation.
    Omar MA; El-Shiekh RA; Dawood DH; Temirak A; Srour AM
    Future Med Chem; 2023 Dec; 15(24):2269-2287. PubMed ID: 37994559
    [No Abstract]   [Full Text] [Related]  

  • 2. Barbiturate-sulfonate hybrids as potent cholinesterase inhibitors: design, synthesis and molecular modeling studies.
    Kassem AF; Omar MA; Temirak A; El-Shiekh RA; Srour AM
    Future Med Chem; 2024 Aug; 16(16):1615-1631. PubMed ID: 39011621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and molecular modelling of thiadizole based hydrazone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitory activities.
    Işık A; Acar Çevik U; Karayel A; Celik I; Erçetin T; Koçak A; Özkay Y; Kaplancıklı ZA
    SAR QSAR Environ Res; 2022 Mar; 33(3):193-214. PubMed ID: 35243936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies.
    Bozbey İ; Özdemir Z; Uslu H; Özçelik AB; Şenol FS; Orhan İE; Uysal M
    Mini Rev Med Chem; 2020; 20(11):1042-1060. PubMed ID: 31660824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, molecular modeling, in vitro evaluation of novel piperidine-containing hydrazone derivatives as cholinesterase inhibitors.
    Tok F; Baltaş N; Abas Bİ; Tatar Yılmaz G; Kaya S; Koçyiğit-Kaymakçıoğlu B; Çevik Ö
    Drug Dev Res; 2024 Aug; 85(5):e22240. PubMed ID: 39105636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and molecular docking simulation of new benzimidazole-thiazole hybrids as cholinesterase inhibitors.
    Dawood DH; Srour AM; Omar MA; Farghaly TA; El-Shiekh RA
    Arch Pharm (Weinheim); 2024 Jan; 357(1):e2300201. PubMed ID: 37937360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactive sulfonyl hydrazones with alkyl derivative: Characterization, ADME properties, molecular docking studies and investigation of inhibition on choline esterase enzymes for the diagnosis of Alzheimer's disease.
    Bilen E; Özdemir Özmen Ü; Çete S; Alyar S; Yaşar A
    Chem Biol Interact; 2022 Jun; 360():109956. PubMed ID: 35452634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Molecular Docking of New Bis-Thiazolidinone-Based Chalcone Analogs as Effective Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
    Hussain R; Rahim F; Rehman W; Taha M; Khan S; Zaman K; Adnan Ali Shah S; Wadood A; Imran S; Abdellatif MH
    Chem Biodivers; 2022 Oct; 19(10):e202200323. PubMed ID: 35997224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.
    Parlar S; Bayraktar G; Tarikogullari AH; Alptüzün V; Erciyas E
    Chem Pharm Bull (Tokyo); 2016; 64(9):1281-7. PubMed ID: 27581632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
    Karaman N; Sıcak Y; Taşkın-Tok T; Öztürk M; Karaküçük-İyidoğan A; Dikmen M; Koçyiğit-Kaymakçıoğlu B; Oruç-Emre EE
    Eur J Med Chem; 2016 Nov; 124():270-283. PubMed ID: 27592396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis, and Biological Evaluation of Novel Indanone Derivatives as Cholinesterase Inhibitors for Potential Use in Alzheimer's Disease.
    Etemadi A; Hemmati S; Shahrivar-Gargari M; Abibiglue YT; Bavili A; Hamzeh-Mivehroud M; Dastmalchi S
    Chem Biodivers; 2023 Aug; 20(8):e202300075. PubMed ID: 37458518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel cinnamic acid-tryptamine hybrids as potent butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
    Ghafary S; Najafi Z; Mohammadi-Khanaposhtani M; Nadri H; Edraki N; Ayashi N; Larijani B; Amini M; Mahdavi M
    Arch Pharm (Weinheim); 2018 Oct; 351(10):e1800115. PubMed ID: 30284339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
    Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
    Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring indole-based-thiadiazole derivatives as potent acetylcholinesterase and butyrylcholinesterase enzyme inhibitors.
    Taha M; Rahim F; Uddin N; Khan IU; Iqbal N; Anouar EH; Salahuddin M; Farooq RK; Gollapalli M; Khan KM; Zafar A
    Int J Biol Macromol; 2021 Oct; 188():1025-1036. PubMed ID: 34390751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
    Sadafi Kohnehshahri M; Chehardoli G; Bahiraei M; Akbarzadeh T; Ranjbar A; Rastegari A; Najafi Z
    Mol Divers; 2022 Feb; 26(1):489-503. PubMed ID: 34491490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, in silico and in vitro studies of hydrazide-hydrazone imine derivatives as potential cholinesterase inhibitors.
    Güngör SA
    Chem Biol Drug Des; 2023 Oct; 102(4):676-691. PubMed ID: 37258044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active compounds from a diverse library of triazolothiadiazole and triazolothiadiazine scaffolds: synthesis, crystal structure determination, cytotoxicity, cholinesterase inhibitory activity, and binding mode analysis.
    Khan I; Ibrar A; Zaib S; Ahmad S; Furtmann N; Hameed S; Simpson J; Bajorath J; Iqbal J
    Bioorg Med Chem; 2014 Nov; 22(21):6163-73. PubMed ID: 25257911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer's Diseases.
    Guo Y; Yang H; Huang Z; Tian S; Li Q; Du C; Chen T; Liu Y; Sun H; Liu Z
    Molecules; 2020 Jan; 25(3):. PubMed ID: 31979317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of benzodiazepine-1,2,3-triazole hybrid derivatives as selective butyrylcholinesterase inhibitors.
    Mehrazar M; Hassankalhori M; Toolabi M; Goli F; Moghimi S; Nadri H; Bukhari SNA; Firoozpour L; Foroumadi A
    Mol Divers; 2020 Nov; 24(4):997-1013. PubMed ID: 31845210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
    Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.